CHANGES IN INTRAOCULAR PRESSURE AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB IN PATIENTS OF DIABETIC MACULAR OEDEMA. FMHR 2025, 3 (5), 2077-2081.